| Literature DB >> 31660009 |
Eugenio Cersosimo1, Pearl G Lee2, Naushira Pandya3.
Abstract
IN BRIEF The use of long-acting basal insulin analogs is a recommended strategy in older people with diabetes because of their lower risk of hypoglycemia compared to intermediate-acting insulins. In this article, we review the results from recent clinical trials of second-generation basal insulin preparations. We conclude that, although these preparations have improved the management of insulin-requiring older people with type 2 diabetes, there is a need for additional and more specific studies to address the complexities of hyperglycemia management in this population.Entities:
Year: 2019 PMID: 31660009 PMCID: PMC6794221 DOI: 10.2337/cd18-0074
Source DB: PubMed Journal: Clin Diabetes ISSN: 0891-8929